ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Bears Eye Memory Chips, Distressed Names

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Options flow on August 1 tells a split story. Bearish bets dominate in memory hardware. Bullish money is also landing in the same sector — a sign of high conviction on both sides.

Sandisk tops the negative options bets table over the past week. The stock is up 412% year-to-date, making it a prime target for those betting the rally is overdone. Micron Technology ranks first for both bullish and bearish bets. That dual signal points to a classic pre-earnings positioning squeeze. Micron's ORTEX stock score sits at 97 out of 100, yet its RSI of 43 tells a more cautious technical story.

Earnings season is driving most of the noise. Hertz Global Holdings carries an ORTEX short score of 77. The stock is down 69% year-to-date. Options traders are pricing in further pain. Days-to-cover stands at 13.5 — that's a very crowded short.

Chewy draws attention too. Bears have pressed it hard this week. Its short score is nearly 60. The stock has lost 32% in 2026.

On the biotech front, Regeneron Pharmaceuticals has an RSI of 78. That's near overbought territory. Its Q2 earnings call is scheduled. Option positioning around those results will be key.

Tesla sits at an RSI of 31.7. Down 31% year-to-date. It draws some of the market's highest negative options bets. Bears remain active even at these depressed levels.

This article is not financial advice.

Stocks in this article

How this article was generated

Generated
1 Aug 2026, 16:42
Prompt version
v1.0
Data sources
Options flowORTEX Alpha signals

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.